Peptides: their role in excess alcohol drinking and their promise as a therapeutic tool.
Egli
Mark
M
Division of Basic Research, The National Institute on Alcoholism and Alcohol Abuse, National Institutes of Health, Department of Health and Human Services, 6000 Executive Boulevard, Bethesda, MD 20892, USA. megli@willco.niaaa.nih.gov
D000428:Alcohol Drinking / Q000235:genetics* / Q000503:physiopathology / Q000517:prevention & control; D000437:Alcoholism / Q000235:genetics* / Q000503:physiopathology / Q000534:rehabilitation; D000818:Animals; D004195:Disease Models, Animal; D000431:Ethanol / Q000633:toxicity; D006801:Humans; D020738:Leptin / Q000235:genetics / Q000502:physiology; D009042:Motivation; D009478:Neuropeptide Y / Q000235:genetics / Q000502:physiology; D009479:Neuropeptides / Q000502:physiology*; D051381:Rats; D013375:Substance Withdrawal Syndrome / Q000235:genetics / Q000503:physiopathology
D020738:Leptin; D009478:Neuropeptide Y; D009479:Neuropeptides; D000431:Ethanol